When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
about
Elimination of perinatal HIV infection in the USA and other high-income countries: achievements and challengesMother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuumDetectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho StudyPatient factors to target for elimination of mother-to-child transmission of HIV.Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort studyUniversal children's day--let's improve current interventions to reduce vertical transmission of HIV nowPredictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort studyNo perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral TreatmentUK national clinical audit: management of pregnancies in women with HIVSocio-economic, clinical and biological risk factors for mother - to - child transmission of HIV-1 in Muhima health centre (Rwanda): a prospective cohort study.Antiretrovirals and safer conception for HIV-serodiscordant couplesIntegrase inhibitors in late pregnancy and rapid HIV viral load reduction.Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women.Compassionate Love as a Predictor of Reduced HIV Disease Progression and Transmission Risk.A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy.Timing of maternal HIV testing and uptake of prevention of mother-to-child transmission interventions among women and their infected infants in Johannesburg, South Africa.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.Management and outcomes of pregnancies among women with HIV in Oxford, UK, in 2008-2012.Low uptake of HIV testing and no HIV positivity in stable serodiscordant heterosexual partners of long-term treated HIV-infected Thais.Spiritual coping predicts CD4-cell preservation and undetectable viral load over four years.Maternal mortality among HIV-infected pregnant women in Tanzania.Low prevalence of renal dysfunction in HIV-infected pregnant women: implications for guidelines for the prevention of mother-to-child transmission of HIV.HIV seroconversion in the third trimester of pregnancy: using raltegravir to prevent mother-to-child transmission.Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.British HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860
Q26998146-C144C4CC-79D2-46C3-B44F-0A0116388C92Q28082436-27AC7876-9EB3-437D-8952-81F6840C8A91Q28555187-4AA5B620-7CB0-4FE2-86B0-FCEF0EDDACB4Q33631671-715F9DE9-E866-4A04-8A41-8CF72F594C04Q33654652-C4A22BE4-9716-42A9-AE3C-A01DEDA00015Q33714594-9F1D0B35-C062-46B9-8DBA-BF51986CE209Q34410294-7FCD285C-E40A-4521-B39D-D951B0332D65Q34558511-1C139DE1-C2E1-4F8B-BFF5-35B49ED5058EQ34649171-907403F0-2E60-4ED6-94E0-603A7DA13EBCQ34988296-9D6CAA1A-4C56-44F7-8DE5-F967424481A7Q35703796-4A93CE59-7259-4343-8E87-23936046C3BEQ35861475-1EB6DABD-198B-42FC-B32E-AA564EDC68B5Q36285536-EB9D8CFE-4732-4365-9EA5-DB6069716C78Q36688427-18A78809-B839-437E-B3BA-BBBCA0ADDA57Q36964167-65F141B9-1EDF-47BD-9CDD-0CFACDE0144DQ37199763-AB562A8A-CFDA-47FA-B673-AD6B13D2F70DQ37259753-A724D712-7C88-4646-9FA9-39B1E09E17AFQ37367568-811AE21D-2D68-4379-9288-FE8439FAF147Q37486409-20FCB46C-6324-4249-A1AE-E1EB53755367Q37723043-117C31DA-A8E5-494B-A286-8F8DFB46FB30Q38325427-1D3259CF-13ED-4401-8857-F4DE26C92586Q39648148-D2900891-695A-4667-A6B4-9A8927C20777Q41286225-B44300D0-A618-412C-AE49-5E478049C7FFQ41599322-ADC931BD-3305-4AFE-8560-C8010880A9ADQ41710088-959B6C8D-C7B8-4DC2-AF53-1E0139CF2DF6Q42224617-5D40AE5B-8EDA-41E6-B967-36331173B520Q42245194-767BCB43-53FA-4989-AD3A-2D136D7D54E6Q42273377-C694D06D-89B0-429E-9A05-FF9FB4F4EEB0Q42318291-9F706E26-7DD4-44C5-AD4C-E11139212948Q45326424-CB51ADAA-CF86-4E2D-9BAE-E3AB7C1D9912Q55361139-85328D29-412A-421C-8DA8-127666E04AD7Q57076282-BC93BC68-91E0-49CF-A6E1-611F1FE6F8C1
P2860
When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
When should HAART be initiated ...... le HIV viral load by delivery?
@en
When should HAART be initiated ...... le HIV viral load by delivery?
@nl
type
label
When should HAART be initiated ...... le HIV viral load by delivery?
@en
When should HAART be initiated ...... le HIV viral load by delivery?
@nl
prefLabel
When should HAART be initiated ...... le HIV viral load by delivery?
@en
When should HAART be initiated ...... le HIV viral load by delivery?
@nl
P2093
P1433
P1476
When should HAART be initiated ...... le HIV viral load by delivery?
@en
P2093
Annemiek de Ruiter
Claire Naftalin
David A Hawkins
Graham P Taylor
London HIV Perinatal Research Group
Palwasha Khan
Phillip J Read
Sundhiya Mandalia
Ursula Harrisson
P304
P356
10.1097/QAD.0B013E3283536A6C
P407
P577
2012-06-01T00:00:00Z